日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER Trial

对既往预防性治疗失败且自述合并精神疾病的偏头痛患者，依普汀单抗的持续疗效：安慰剂对照 DELIVER 试验的事后分析

期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-026-00893-4
Pozo-Rosich, Patricia; Tassorelli, Cristina; Boserup, Line Pickering; Awad, Susanne F; Lee, Xin Ying; Ailani, Jessica
偏头痛
神经科学
发表日期：2026
文献求助 收藏

Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have Failed

对于接受依普汀单抗治疗且既往2-4种预防性治疗均失败的偏头痛患者，在初始偏头痛缓解后可观察到长期改善

期刊:European Journal of Neurology
影响因子:3.9
doi:10.1111/ene.70571
Ailani, Jessica; Ashina, Messoud; Awad, Susanne F; Lee, Xin Ying; Boserup, Line Pickering; Soni-Brahmbhatt, Seema; Sperling, Bjørn; Lipton, Richard B
偏头痛
神经科学
发表日期：2026
文献求助 收藏

Pharmacokinetics and safety of eptinezumab in children and adolescents with migraine

eptinezumab 在儿童和青少年偏头痛患者中的药代动力学和安全性

期刊:Headache
影响因子:4
doi:10.1111/head.14959
Hershey, Andrew D; Areberg, Johan; Boserup, Line Pickering; Lindsten, Annika; Rosen, Monika
偏头痛
神经科学
发表日期：2025
文献求助 收藏

Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial

在既往预防性治疗失败的偏头痛患者中，接受依普汀单抗治疗后，急性头痛药物使用量长期减少：DELIVER随机试验的事后分析

期刊:Headache
影响因子:4
doi:10.1111/head.14862
Gryglas-Dworak, Anna; Schim, Jack; Ettrup, Anders; Boserup, Line Pickering; Josiassen, Mette Krog; Ranc, Kristina; Sperling, Bjørn; Ashina, Messoud
偏头痛
神经科学
发表日期：2025
文献求助 收藏

Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed

对既往预防性治疗失败的成人偏头痛患者，使用抗CGRP单克隆抗体进行偏头痛预防的治疗所需人数和每位有效患者成本分析

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03348-8
Mitsikostas, Dimos D; Awad, Susanne F; Kongerslev, Rikke; Boserup, Line Pickering; Lee, Xin Ying; Phul, Ravinder; Sacco, Simona
单克隆抗体
偏头痛
CGRP
神经科学
发表日期：2025
文献求助 收藏

Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial

对于既往接受过 2-4 种预防性治疗但均失败的偏头痛成人患者，依普汀单抗治疗后头痛天数频率出现早期且持续的变化：一项随机 DELIVER 试验的事后分析

期刊:European Journal of Neurology
影响因子:3.9
doi:10.1111/ene.70460
Tassorelli, Cristina; Starling, Amaal J; Awad, Susanne F; Lee, Xin Ying; Boserup, Line Pickering; Asher, Divya; Soni-Brahmbhatt, Seema; Sperling, Bjørn; Goadsby, Peter J
偏头痛
神经科学
发表日期：2025
文献求助 收藏

Eptinezumab for migraine prevention after other treatments fail: a plain language summary of publications

其他治疗无效后，Eptinezumab 用于预防偏头痛：文献综述（简明语言版）

期刊:Pain Management
影响因子:1.5
doi:10.1080/17581869.2025.2514425
Ashina, Messoud; de la Torre, Elena Ruiz; Boserup, Line Pickering; Ettrup, Anders; Starling, Amaal J
偏头痛
神经科学
发表日期：2025
文献求助 收藏

Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study

无论既往预防性偏头痛治疗失败类型如何，Eptinezumab 均显示出疗效：DELIVER 研究的事后分析

期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-023-00575-5
Pozo-Rosich, Patricia; Ashina, Messoud; Tepper, Stewart J; Jensen, Sidsel; Boserup, Line Pickering; Josiassen, Mette Krog; Sperling, Bjørn
偏头痛
神经科学
发表日期：2024
文献求助 收藏